 Clinical electrophysiologic determinants treatment survival patients sustained malignant ventricular tachyarrhythmias myocardial infarction clinical electrophysiologic determinants treatment survival patients sustained malignant ventricular tachyarrhythmias myocardial infarction total patients mean age years Thirty-two patients Group ventricular tachyarrhythmias days mean acute myocardial infarction patients Group II control group ventricular tachyarrhythmias equal days infarction significant independent determinants sustained ventricular tachyarrhythmias infarction presence late potentials chi square abnormal signal-averaged QRS complex association abnormal root-mean-square voltage terminal ms QRS complex abnormal ejection fraction chi square ventricular tachycardia Group patients patients Group therapy antiarrhythmic drug therapy sole preventive measure map-guided surgery coronary artery bypass surgery automatic cardioverter-defibrillator arrhythmias noninducible patients map-guided surgery drug therapy follow-up period months Group patients arrhythmic event cardiac-related death patients arrhythmic event antiarrhythmic drug therapy